-

EVVTY STOCK NEWS: Investors with Large Losses Should Contact Robbins LLP for Information About the Class Action Against Evolution AB (publ)

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Evolution AB (OTC: EVVTY) American Depository Shares (ADSs) between February 14, 2019 and October 25, 2023. Evolution is a global online gaming company that develops, produces, markets, licenses, and runs online casino solutions.

For more information, submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is this Case About: Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects

According to the complaint, on January 24, 2022, Analyst Alpha Generation Limited released a report on Evolution to certain institutional investors. According to subsequent media coverage, the report stated that (1) a significant portion of Evolution's revenue "could be at risk due to future regulatory clampdowns," and (2) Evolution was "exposed to revenues from what we [the authors of the Report] believe to be illegal gambling activities." On this news, Evolution's ADS price fell $19.78 per ADS, or approximately 15%, over the following three trading sessions, to close at $115.00 per ADS on January 27, 2022.

On April 26, 2022, Australia's gambling regulator announced that it had requested that Australian internet service providers block six online gambling sites, the operators of at least five of which were direct or indirect customers of Evolution, alleging that the sites were engaged in illegal gambling. On this news, Evolution's ADS price fell $6.02 per ADS over the following two trading sessions, to close at $96.73 per ADS on April 27, 2022.

On May 4, 2022, industry press reported that the Swedish Administrative Court had upheld most of the record Swedish fines of 175 million Swedish Krona (approximately $17.8 million) that had been imposed on brands operated by ComeOn Group, a subsidiary of Cherry AB (publ), a customer of Evolution, in relation to breaches of Swedish online gambling regulations. On this news, Evolution's ADS price fell $12.34 per ADS, or approximately 11%, to close at $101.09 per ADS on May 5, 2022.

On May 7, 2022, media outlets reported that industry participants had lobbied the UK government against an overhaul of gambling laws in the UK. On this news, Evolution's ADS price fell $14.84 per ADS over the following three trading sessions, to close at $87.25 per ADS on May 11, 2022.

On April 27, 2023, Evolution released its financial and operating results for the first quarter of 2023. Among other items, the Company disclosed that revenue from the RNG segment of its business did not grow, and that its North American business segment had experienced a low growth rate. On this news, Evolution's ADS price fell $10.94 per ADS over the following four trading sessions, to close at $125.26 per ADS on May 2, 2023.

Finally, on October 26, 2023, Evolution released its financial and operating results for the third quarter of 2023 and held an analyst call to discuss the results. In both, Evolution disclosed that the Company faced delays in opening new studios and that revenues for its RNG and North American business segments did not grow. On this news, Evolution's ADS price fell $7.15 per ADS over the following two trading sessions, to close at $86.80 per ADS on October 27, 2023.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Evolution AB. Shareholders who want to act as lead plaintiff for the class should contact Robbins LLP. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Evolution AB settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

OTC Pink:EVVTY

Release Summary
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the SES AI Corporation Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired SES AI Corporation (NYSE: SES) securities between January 29, 2025 and March 4, 2026. SES claims to be a "leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion”) rechargeable battery technologies and battery materials for Energy Storage Systems (“ESS”), Urban Air Mobility (“UAM”)...

Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

Investor Notice: Robbins LLP Informs Investors of the Globant S.A. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Globant S.A. (NYSE: GLOB) common stock between February 15, 2024 and August 14, 2025. Globant is a Luxembourg-incorporated international technology company that provides digital consulting and related services. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LL...
Back to Newsroom